Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

LeptoVax 4/C + LymeVax

This page contains information on LeptoVax 4/C + LymeVax for veterinary use.
The information provided typically includes the following:
  • LeptoVax 4/C + LymeVax Indications
  • Warnings and cautions for LeptoVax 4/C + LymeVax
  • Direction and dosage information for LeptoVax 4/C + LymeVax

Leptovax 4/c + Lymevax

This treatment applies to the following species:
Manufacturer: Boehringer Ingelheim

Canine Coronavirus Vaccine, Killed Virus

borrelia Burgdorferi Bacterin-leptospira Canicola-grippotyphosa-icterohaemorrhagiae-pomona Bacterial Extract

For Use In Dogs Only

For Veterinary Use Only

For subcutaneous vaccination of healthy dogs 9 weeks of age or older as an aid in the prevention of disease caused by canine coronavirus, Borrelia burgdorferi, Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae and Leptospira pomona.

Dosage And Route Of Administration

Administer one 1 mL dose subcutaneously. The presence of maternal antibody is known to interfere with the development of active immunity. A vaccination series with Duramune® Cv-K or other Duramune products containing coronavirus should start at 6 weeks of age. Puppies should be revaccinated every 2 to 3 weeks until at least 16 weeks of age. Vaccination or revaccination with this product should begin at or about 9 weeks of age. All dogs over 12 weeks of age should initially receive one dose of this product and a second dose 2 to 3 weeks later. Annual revaccination with one dose is recommended.

The PEEL-OFF LABEL I.D. SYSTEM provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.

For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal’s medical chart.

Using The System


Grasp the vial label at the corner marked with an indicator arrow, between your thumb and forefinger (figure 1).


Pull steadily at a slight angle until the label is separated from the vial (figure 2).


Place the label on the animal’s medical chart. Press down on the label to ensure adhesion.

LeptoVax 4/C + LymeVax Caution

DO NOT USE AS DILUENT FOR LIVE VACCINES. Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. In case of anaphylactoid reaction, administer epinephrine. Burn container and all unused contents.

Gentamicin and thimerosal added as preservatives.

LeptoVax 4/C + LymeVax Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

LeptoVax®, Duramune® and Duramune® Lyme™ are registered trademarks of Boehringer Ingelheim Vetmedica, Inc.

©2010 Boehringer Ingelheim Vetmedica, Inc. All Rights Reserved.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Mo 64506 U.s.a.

U.s. Veterinary License No. 124

25 Doses:

25 x 1 mL Vials of Vaccine


Nac No.

Telephone:   800-325-9167
Fax:   816-236-2717
Every effort has been made to ensure the accuracy of the LeptoVax 4/C + LymeVax information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-04-26